Omalizumab also successful in chronic urticaria.
Spector
Sheldon L
SL
Tan
Ricardo A
RA
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology; D000069444:Omalizumab; D014581:Urticaria / Q000097:blood / Q000188:drug therapy* / Q000276:immunology
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E